Source: PR Newswire

Press Release: Indivumed GmbH : European Union-Funded Project to Result in Novel Treatment Approaches for Several Solid Tumor Types

/PRNewswire/ -- Indivumed GmbH ("Indivumed") and CELLphenomics GmbH ("CELLphenomics") today announced a partnership to create a unique platform for faster and...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Hartmut Juhl's photo - Founder & CEO of Indivumed GmbH

Founder & CEO

Hartmut Juhl

CEO Approval Rating

82/100

Read more